Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01995461 · ClinicalTrials.gov registry record · NA
Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis
A NA study, sponsored by Marshfield Clinic Research Foundation.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01995461 is a NA study that was terminated before completion, run by Marshfield Clinic Research Foundation. The registered enrollment target is 26 participants.
The verdict
NCT01995461, a NA study, was terminated before completion, sponsored by Marshfield Clinic Research Foundation.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The most common forms of injection used for the treatment of degenerative lumbar spinal stenosis (DLSS) patients with neurogenic claudication (NC) are the caudal and inter-laminar epidural injections of anesthetic and steroid. Unilateral transforaminal epidural steroid injections (TESI) are also used to alleviate patients' symptoms of NC from DLSS, particularly in patients whose level of stenosis is L4-5 or higher. However, these unilateral injections do not cross the midline, so in cases of lower extremity pain and symptoms on both sides, a bilateral TESI would probably be more beneficial. To date, there have not been any well designed prospective studies to determine the effectiveness of bilateral TESI below the level of stenosis in DLSS patients with NC. Therefore, the goal of this prospective, non-randomized case-series outcome study is to evaluate the effectiveness of BTESI in alleviating symptoms of NC, as well as improving function in patients with DLSS. The hypothesis is that BTESI at the level below the most stenotic segment of the central canal of the lumbar spine decreases symptoms of NC and improves function in patients with DLSS.
Interventions
- DRUG bilateral transforaminal epidural steroid injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01995461
The ClinicalTrials.gov registry entry for NCT01995461 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marshfield Clinic Research Foundation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bilateral transforaminal epidural steroid injections is the first listed.
NCT01995461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01995461 about?
NCT01995461 is a clinical study titled "Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis". The most common forms of injection used for the treatment of degenerative lumbar spinal stenosis (DLSS) patients with neurogenic claudication (NC) are the caudal and inter-laminar epidural injections of anesthetic and steroid. Unilateral transforaminal epidural steroid injections (TESI) are also use...
What is the current status of trial NCT01995461?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2013-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01995461?
The interventions under investigation include: bilateral transforaminal epidural steroid injections (DRUG).
Who is sponsoring clinical trial NCT01995461?
This trial is sponsored by Marshfield Clinic Research Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.